[New Product] Completion of Development and Launch of IL-15 Alternative Peptide
2025/12/17
We have successfully developed a peptide that demonstrates high affinity and agonist activity against IL-2Rβ and common γ-chain, similar to Interleukin-15 (IL-15). Starting from December 2025, we will start selling the IL-15 Alternative Peptide under the product code "PG-013".
PG-013 is a cytokine that induces the activation and proliferation of immune cells. In the fields of regenerative medicine and cell therapy, it is intended for use in the culture and functional enhancement of immune cells such as T cells, NK cells, and NKT cells.
We can provide the free sample. Please feel free to contact us from [contact].
